Physician profile
Gavin Huber
NPI 1336689108
$3,828.93
in general payments reported to CMS, 2019-2025
10 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.48 · 2022: $56.16 · 2023: $3,475 · 2024: $17.37 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,891 · Education: $1,500 · Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,891.17 |
| Education | $1,500.00 |
| Food and Beverage | $363.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,784.13 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $693.53 | 2023 | Matrixrib |
| Smith+Nephew, INC. | $73.94 | 2024-2025 | Oasis, Stravix Pl, Grafix Pl |
| Davol INC. | $56.16 | 2022 | |
| Access Pro Medical, LLC | $54.93 | 2025 | Matriderm |
| Kerecis Limited | $52.98 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $52.52 | 2025 | Transorb |
| Vertex Pharmaceuticals Incorporated | $23.57 | 2025 | |
| Octapharma USA, INC. | $18.69 | 2025 | Fibryga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavin Huber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.